These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19686517)

  • 21. Epidemiology and health service resource allocation policy for alcohol, drug abuse, and mental disorders.
    Regier DA; Shapiro S; Kessler LG; Taube CA
    Public Health Rep; 1984; 99(5):483-92. PubMed ID: 6435161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The burden of death, disease, and disability due to alcohol in New Zealand.
    Connor J; Broad J; Rehm J; Vander Hoorn S; Jackson R
    N Z Med J; 2005 Apr; 118(1213):U1412. PubMed ID: 15843841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of mental health on labour market outcomes in China.
    Lu C; Frank RG; Liu Y; Shen J
    J Ment Health Policy Econ; 2009 Sep; 12(3):157-66. PubMed ID: 19996477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The global burden due to occupational injury.
    Concha-Barrientos M; Nelson DI; Fingerhut M; Driscoll T; Leigh J
    Am J Ind Med; 2005 Dec; 48(6):470-81. PubMed ID: 16299709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies.
    Wittchen HU; Jacobi F
    Eur Neuropsychopharmacol; 2005 Aug; 15(4):357-76. PubMed ID: 15961293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent epidemiologic data on illicit drugs in France: prevalence and health impact of consumption, availability, and product quality].
    Costes JM
    Bull Acad Natl Med; 2002; 186(2):281-94. PubMed ID: 12145836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of illicit drug use in Asia and the Pacific.
    Devaney ML; Reid G; Baldwin S
    Drug Alcohol Rev; 2007 Jan; 26(1):97-102. PubMed ID: 17364842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment associated with sleep problems in the community: relationship to physical and mental health comorbidity.
    Stein MB; Belik SL; Jacobi F; Sareen J
    Psychosom Med; 2008 Oct; 70(8):913-9. PubMed ID: 18842741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The global burden of selected occupational diseases and injury risks: Methodology and summary.
    Nelson DI; Concha-Barrientos M; Driscoll T; Steenland K; Fingerhut M; Punnett L; Prüss-Ustün A; Leigh J; Corvalan C
    Am J Ind Med; 2005 Dec; 48(6):400-18. PubMed ID: 16299700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
    Breman JG; Alilio MS; Mills A
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):1-15. PubMed ID: 15331814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Illicit drug use and responses in six Pacific Island countries.
    Devaney ML; Reid G; Baldwin S; Crofts N; Power R
    Drug Alcohol Rev; 2006 Jul; 25(4):387-90. PubMed ID: 16854668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Illicit peyote use among American Indian adolescents in substance abuse treatment: a preliminary investigation.
    Fickenscher A; Novins DK; Manson SM
    Subst Use Misuse; 2006; 41(8):1139-54. PubMed ID: 16798681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National and sub-national prevalence, trend, and burden of mental disorders and substance abuse in Iran: 1990 - 2013, study protocol.
    Naserbakht M; Djalalinia S; Tayefi B; Gholami M; Eftekhar Ardabili M; Shariat SV; Taban M; Hajebi A; Behtaj F; Sajadi SA; Rahimi-Movaghar A; Moradi-Lakeh M; Farzadfar F
    Arch Iran Med; 2014 Mar; 17(3):182-8. PubMed ID: 24621361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being.
    Degenhardt L; Hall W
    Nicotine Tob Res; 2001 Aug; 3(3):225-34. PubMed ID: 11506766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demand for illicit drugs among pregnant women.
    Corman H; Noonan K; Reichman NE; Dave D
    Adv Health Econ Health Serv Res; 2005; 16():41-60. PubMed ID: 17867234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of estimates of the global burden of injury and illness due to occupational exposures.
    Driscoll T; Takala J; Steenland K; Corvalan C; Fingerhut M
    Am J Ind Med; 2005 Dec; 48(6):491-502. PubMed ID: 16299705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counting the cost: estimating the burden of child mental health.
    Maughan B
    J Child Psychol Psychiatry; 2013 Dec; 54(12):1261-2. PubMed ID: 24237417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.